Evaluation of a US Food and Drug Administration mandate to limit acetaminophen in prescription combination products

Goldberger David; Vearrier David

首页> 外文期刊>Clinical toxicology: the official journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists >Evaluation of a US Food and Drug Administration mandate to limit acetaminophen in prescription combination products

【24h】

Evaluation of a US Food and Drug Administration mandate to limit acetaminophen in prescription combination products

机译：评估美国食品和药物管理局的任务要求在处方组合产品中限制乙酰氨基酚

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Clinical toxicology: the official journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists》 |2017年第5期|共1页
作者
Goldberger David; Vearrier David;
展开▼
作者单位

Drexel Univ Coll Med Philadelphia PA 19104 USA;

Drexel Univ Coll Med Philadelphia PA 19104 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类毒物学（毒理学）;
关键词

相似文献

外文文献
中文文献
专利

1. Comment on: Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products [J] . Michael E. Mullins, S. Eliza Dunn Journal of medical toxicology: official journal of the American College of Medical Toxicology . 2018,第1期

机译：评论：评估食品和药物管理局的任务要求在处方组合产品中限制乙酰氨基酚
2. Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products [J] . David Goldberger, David Vearrier Journal of medical toxicology: official journal of the American College of Medical Toxicology . 2017,第4期

机译：评估食品和药物管理局的授权，限制处方组合产品中的乙酰氨基酚
3. Evaluation of a US Food and Drug Administration mandate to limit acetaminophen in prescription combination products [J] . Goldberger David, Vearrier David Clinical toxicology: the official journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists . 2017,第5期

机译：评估美国食品和药物管理局的任务要求在处方组合产品中限制乙酰氨基酚
4. Telematics Integrated System to Perform Drugs Prescription and Administration Reducing Adverse Drug Events [C] . E. Iadanza, M.C. Pettenati, L. Bianchi, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2012

机译：远程信息处理综合系统进行药物处方和管理减少不良药物事件
5. The Food and Drug Administration's new drug approvals and market withdrawals for safety under the Prescription Drug User Fee Act and the Food and Drug Modernization Act. [D] . Dziurzynski, Bogdan. 2005

机译：食品和药物管理局根据《处方药使用者费用法》和《食品和药物现代化法》为安全起见批准了新药，并撤出了市场。
6. Comment on: Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products [O] . Michael E. Mullins, S. Eliza Dunn 2018

机译：评论：食品药品管理局限制处方组合产品中对乙酰氨基酚含量的评估
7. Evaluation of a Food and Drug Administration Mandate to Limit Acetaminophen in Prescription Combination Products [O] . David Goldberger, David Vearrier 2017

机译：评估食品和药物管理局的授权，以限制处方组合产品中的乙酰氨基酚
8. Prescription Drug Products for Which the Food and Drug Administration Has Made a Finding of Suitability for Abbreviated New Drug Applications [R] . Gerstenzang, H. 1983

机译：食品药品管理局为缩短的新药申请提供适用性的处方药产品

Evaluation of a US Food and Drug Administration mandate to limit acetaminophen in prescription combination products

著录项

相似文献

相关主题

期刊订阅